Andrea N Burnett-Hartman1, Shivan J Mehta2, Yingye Zheng3, Nirupa R Ghai4, Dale F McLerran3, Jessica Chubak5, Virginia P Quinn4, Celette Sugg Skinner6, Douglas A Corley7, John M Inadomi8, Chyke A Doubeni9. 1. Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado; Fred Hutchinson Cancer Research Center, Seattle, Washington. Electronic address: andrea.n.burnett-hartman@kp.org. 2. Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. 3. Fred Hutchinson Cancer Research Center, Seattle, Washington. 4. Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California. 5. Group Health Research Institute, Seattle, Washington. 6. University of Texas Southwestern Medical Center and the Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas. 7. Division of Research, Kaiser Permanente Northern California, Oakland, California. 8. Division of Gastroenterology, University of Washington, School of Medicine, Seattle, Washington. 9. Department of Family Medicine and Community Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Abstract
INTRODUCTION: Racial/ethnic disparities in colorectal cancer (CRC) screening and diagnostic testing present challenges to CRC prevention programs. Thus, it is important to understand how differences in CRC screening approaches between healthcare systems are associated with racial/ethnic disparities. METHODS: This was a retrospective cohort study of patients aged 50-75 years who were members of the Population-based Research Optimizing Screening Through Personalized Regimens cohort from 2010 to 2012. Data on race/ethnicity, CRC screening, and diagnostic testing came from medical records. Data collection occurred in 2014 and analysis in 2015. Logistic regression models were used to calculate AORs and 95% CIs comparing completion of CRC screening between racial/ethnic groups. Analyses were stratified by healthcare system to assess differences between systems. RESULTS: There were 1,746,714 participants across four healthcare systems. Compared with non-Hispanic whites (whites), odds of completing CRC screening were lower for non-Hispanic blacks (blacks) in healthcare systems with high screening rates (AOR=0.86, 95% CI=0.84, 0.88) but similar between blacks and whites in systems with lower screening rates (AOR=1.01, 95% CI=0.93, 1.09). Compared with whites, American Indian/Alaskan Natives had lower odds of completing CRC screening across all healthcare systems (AOR=0.76, 95% CI=0.72, 0.81). Hispanics had similar odds of CRC screening (AOR=0.99, 95% CI=0.98, 1.00) and Asian/Pacific Islanders had higher odds of CRC screening (AOR=1.16, 95% CI=1.15, 1.18) versus whites. CONCLUSIONS: Racial/ethnic differences in CRC screening vary across healthcare systems, particularly for blacks, and may be more pronounced in systems with intensive CRC screening approaches.
INTRODUCTION: Racial/ethnic disparities in colorectal cancer (CRC) screening and diagnostic testing present challenges to CRC prevention programs. Thus, it is important to understand how differences in CRC screening approaches between healthcare systems are associated with racial/ethnic disparities. METHODS: This was a retrospective cohort study of patients aged 50-75 years who were members of the Population-based Research Optimizing Screening Through Personalized Regimens cohort from 2010 to 2012. Data on race/ethnicity, CRC screening, and diagnostic testing came from medical records. Data collection occurred in 2014 and analysis in 2015. Logistic regression models were used to calculate AORs and 95% CIs comparing completion of CRC screening between racial/ethnic groups. Analyses were stratified by healthcare system to assess differences between systems. RESULTS: There were 1,746,714 participants across four healthcare systems. Compared with non-Hispanic whites (whites), odds of completing CRC screening were lower for non-Hispanic blacks (blacks) in healthcare systems with high screening rates (AOR=0.86, 95% CI=0.84, 0.88) but similar between blacks and whites in systems with lower screening rates (AOR=1.01, 95% CI=0.93, 1.09). Compared with whites, American Indian/Alaskan Natives had lower odds of completing CRC screening across all healthcare systems (AOR=0.76, 95% CI=0.72, 0.81). Hispanics had similar odds of CRC screening (AOR=0.99, 95% CI=0.98, 1.00) and Asian/Pacific Islanders had higher odds of CRC screening (AOR=1.16, 95% CI=1.15, 1.18) versus whites. CONCLUSIONS: Racial/ethnic differences in CRC screening vary across healthcare systems, particularly for blacks, and may be more pronounced in systems with intensive CRC screening approaches.
Authors: Jaime Benarroch-Gampel; Kristin M Sheffield; Yu-Li Lin; Yong-Fang Kuo; James S Goodwin; Taylor S Riall Journal: Health Serv Res Date: 2011-12-08 Impact factor: 3.402
Authors: David A Lieberman; Douglas K Rex; Sidney J Winawer; Francis M Giardiello; David A Johnson; Theodore R Levin Journal: Gastroenterology Date: 2012-07-03 Impact factor: 22.682
Authors: J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham Journal: Lancet Date: 1996-11-30 Impact factor: 79.321
Authors: Jasmin A Tiro; Aruna Kamineni; Theodore R Levin; Yingye Zheng; Joanne S Schottinger; Carolyn M Rutter; Douglas A Corley; Celette S Skinner; Jessica Chubak; Chyke A Doubeni; Ethan A Halm; Samir Gupta; Karen J Wernli; Carrie Klabunde Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-06-10 Impact factor: 4.254
Authors: Christian von Wagner; Gianluca Baio; Rosalind Raine; Julia Snowball; Stephen Morris; Wendy Atkin; Austin Obichere; Graham Handley; Richard F Logan; Sandra Rainbow; Stephen Smith; Stephen Halloran; Jane Wardle Journal: Int J Epidemiol Date: 2011-02-17 Impact factor: 7.196
Authors: Jennifer K Coury; Jennifer L Schneider; Beverly B Green; Laura-Mae Baldwin; Amanda F Petrik; Jennifer S Rivelli; Malaika R Schwartz; Gloria D Coronado Journal: Transl Behav Med Date: 2020-02-03 Impact factor: 3.046
Authors: Stacey A Fedewa; Douglas A Corley; Christopher D Jensen; Wei Zhao; Michael Goodman; Ahmedin Jemal; Kevin C Ward; Theodore R Levin; Chyke A Doubeni Journal: Am J Prev Med Date: 2017-04-17 Impact factor: 5.043
Authors: William E Barlow; Elisabeth F Beaber; Berta M Geller; Aruna Kamineni; Yingye Zheng; Jennifer S Haas; Chun R Chao; Carolyn M Rutter; Ann G Zauber; Brian L Sprague; Ethan A Halm; Donald L Weaver; Jessica Chubak; V Paul Doria-Rose; Sarah Kobrin; Tracy Onega; Virginia P Quinn; Marilyn M Schapira; Anna N A Tosteson; Douglas A Corley; Celette Sugg Skinner; Mitchell D Schnall; Katrina Armstrong; Cosette M Wheeler; Michael J Silverberg; Bijal A Balasubramanian; Chyke A Doubeni; Dale McLerran; Jasmin A Tiro Journal: J Natl Cancer Inst Date: 2020-03-01 Impact factor: 13.506
Authors: Katherine Ni; Kelli O'Connell; Sanya Anand; Stephanie C Yakoubovitch; Simona C Kwon; Rabia Ali de Latour; Andrew B Wallach; Scott E Sherman; Mengmeng Du; Peter S Liang Journal: Cancer Prev Res (Phila) Date: 2020-02-03
Authors: Krishna P Sharma; Amy DeGroff; Lia Scott; Sundar Shrestha; Stephanie Melillo; Susan A Sabatino Journal: Prev Med Date: 2019-07-15 Impact factor: 4.018